Cargando…
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium
The aldehyde dehydrogenase 2 (ALDH2) polymorphism rs671 (Glu504Lys) causes ALDH2 inactivation and adverse acetaldehyde exposure among Asians, but little is known of the association between alcohol consumption and rs671 and ovarian cancer (OvCa) in Asians. We conducted a pooled analysis of Asian ance...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797830/ https://www.ncbi.nlm.nih.gov/pubmed/29247577 http://dx.doi.org/10.1111/cas.13470 |
_version_ | 1783297760604192768 |
---|---|
author | Ugai, Tomotaka Kelemen, Linda E. Mizuno, Mika Ong, Jue‐Sheng Webb, Penelope M. Chenevix‐Trench, Georgia Wicklund, Kristine G. Doherty, Jennifer Anne Rossing, Mary Anne Thompson, Pamela J. Wilkens, Lynne R. Carney, Michael E. Goodman, Marc T. Schildkraut, Joellen M. Berchuck, Andrew Cramer, Daniel W. Terry, Kathryn L. Cai, Hui Shu, Xiao‐Ou Gao, Yu‐Tang Xiang, Yong‐Bing Van Den Berg, David Pike, Malcom C Wu, Anna H. Pearce, Celeste Leigh Matsuo, Keitaro |
author_facet | Ugai, Tomotaka Kelemen, Linda E. Mizuno, Mika Ong, Jue‐Sheng Webb, Penelope M. Chenevix‐Trench, Georgia Wicklund, Kristine G. Doherty, Jennifer Anne Rossing, Mary Anne Thompson, Pamela J. Wilkens, Lynne R. Carney, Michael E. Goodman, Marc T. Schildkraut, Joellen M. Berchuck, Andrew Cramer, Daniel W. Terry, Kathryn L. Cai, Hui Shu, Xiao‐Ou Gao, Yu‐Tang Xiang, Yong‐Bing Van Den Berg, David Pike, Malcom C Wu, Anna H. Pearce, Celeste Leigh Matsuo, Keitaro |
author_sort | Ugai, Tomotaka |
collection | PubMed |
description | The aldehyde dehydrogenase 2 (ALDH2) polymorphism rs671 (Glu504Lys) causes ALDH2 inactivation and adverse acetaldehyde exposure among Asians, but little is known of the association between alcohol consumption and rs671 and ovarian cancer (OvCa) in Asians. We conducted a pooled analysis of Asian ancestry participants in the Ovarian Cancer Association Consortium. We included seven case‐control studies and one cohort study comprising 460 invasive OvCa cases, 37 borderline mucinous OvCa and 1274 controls of Asian descent with information on recent alcohol consumption. Pooled odds ratios (OR) with 95% confidence intervals (CI) for OvCa risk associated with alcohol consumption, rs671 and their interaction were estimated using logistic regression models adjusted for potential confounders. No significant association was observed for daily alcohol intake with invasive OvCa (OR comparing any consumption to none = 0.83; 95% CI = 0.58‐1.18) or with individual histotypes. A significant decreased risk was seen for carriers of one or both Lys alleles of rs671 for invasive mucinous OvCa (OR = 0.44; 95% CI = 0.20‐0.97) and for invasive and borderline mucinous tumors combined (OR = 0.48; 95% CI = 0.26‐0.89). No significant interaction was observed between alcohol consumption and rs671 genotypes. In conclusion, self‐reported alcohol consumption at the quantities estimated was not associated with OvCa risk among Asians. Because the rs671 Lys allele causes ALDH2 inactivation leading to increased acetaldehyde exposure, the observed inverse genetic association with mucinous ovarian cancer is inferred to mean that alcohol intake may be a risk factor for this histotype. This association will require replication in a larger sample. |
format | Online Article Text |
id | pubmed-5797830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57978302018-02-14 Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium Ugai, Tomotaka Kelemen, Linda E. Mizuno, Mika Ong, Jue‐Sheng Webb, Penelope M. Chenevix‐Trench, Georgia Wicklund, Kristine G. Doherty, Jennifer Anne Rossing, Mary Anne Thompson, Pamela J. Wilkens, Lynne R. Carney, Michael E. Goodman, Marc T. Schildkraut, Joellen M. Berchuck, Andrew Cramer, Daniel W. Terry, Kathryn L. Cai, Hui Shu, Xiao‐Ou Gao, Yu‐Tang Xiang, Yong‐Bing Van Den Berg, David Pike, Malcom C Wu, Anna H. Pearce, Celeste Leigh Matsuo, Keitaro Cancer Sci Original Articles The aldehyde dehydrogenase 2 (ALDH2) polymorphism rs671 (Glu504Lys) causes ALDH2 inactivation and adverse acetaldehyde exposure among Asians, but little is known of the association between alcohol consumption and rs671 and ovarian cancer (OvCa) in Asians. We conducted a pooled analysis of Asian ancestry participants in the Ovarian Cancer Association Consortium. We included seven case‐control studies and one cohort study comprising 460 invasive OvCa cases, 37 borderline mucinous OvCa and 1274 controls of Asian descent with information on recent alcohol consumption. Pooled odds ratios (OR) with 95% confidence intervals (CI) for OvCa risk associated with alcohol consumption, rs671 and their interaction were estimated using logistic regression models adjusted for potential confounders. No significant association was observed for daily alcohol intake with invasive OvCa (OR comparing any consumption to none = 0.83; 95% CI = 0.58‐1.18) or with individual histotypes. A significant decreased risk was seen for carriers of one or both Lys alleles of rs671 for invasive mucinous OvCa (OR = 0.44; 95% CI = 0.20‐0.97) and for invasive and borderline mucinous tumors combined (OR = 0.48; 95% CI = 0.26‐0.89). No significant interaction was observed between alcohol consumption and rs671 genotypes. In conclusion, self‐reported alcohol consumption at the quantities estimated was not associated with OvCa risk among Asians. Because the rs671 Lys allele causes ALDH2 inactivation leading to increased acetaldehyde exposure, the observed inverse genetic association with mucinous ovarian cancer is inferred to mean that alcohol intake may be a risk factor for this histotype. This association will require replication in a larger sample. John Wiley and Sons Inc. 2018-01-21 2018-02 /pmc/articles/PMC5797830/ /pubmed/29247577 http://dx.doi.org/10.1111/cas.13470 Text en © 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Ugai, Tomotaka Kelemen, Linda E. Mizuno, Mika Ong, Jue‐Sheng Webb, Penelope M. Chenevix‐Trench, Georgia Wicklund, Kristine G. Doherty, Jennifer Anne Rossing, Mary Anne Thompson, Pamela J. Wilkens, Lynne R. Carney, Michael E. Goodman, Marc T. Schildkraut, Joellen M. Berchuck, Andrew Cramer, Daniel W. Terry, Kathryn L. Cai, Hui Shu, Xiao‐Ou Gao, Yu‐Tang Xiang, Yong‐Bing Van Den Berg, David Pike, Malcom C Wu, Anna H. Pearce, Celeste Leigh Matsuo, Keitaro Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium |
title | Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium |
title_full | Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium |
title_fullStr | Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium |
title_full_unstemmed | Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium |
title_short | Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium |
title_sort | ovarian cancer risk, aldh2 polymorphism and alcohol drinking: asian data from the ovarian cancer association consortium |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797830/ https://www.ncbi.nlm.nih.gov/pubmed/29247577 http://dx.doi.org/10.1111/cas.13470 |
work_keys_str_mv | AT ugaitomotaka ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT kelemenlindae ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT mizunomika ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT ongjuesheng ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT webbpenelopem ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT chenevixtrenchgeorgia ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT wicklundkristineg ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT dohertyjenniferanne ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT rossingmaryanne ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT thompsonpamelaj ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT wilkenslynner ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT carneymichaele ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT goodmanmarct ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT schildkrautjoellenm ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT berchuckandrew ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT cramerdanielw ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT terrykathrynl ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT caihui ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT shuxiaoou ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT gaoyutang ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT xiangyongbing ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT vandenbergdavid ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT pikemalcomc ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT wuannah ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT pearcecelesteleigh ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT matsuokeitaro ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium AT ovariancancerriskaldh2polymorphismandalcoholdrinkingasiandatafromtheovariancancerassociationconsortium |